TXTM 0.00 ProText Mobility, Inc.
| Range: | 1.0E-4-0.0031 | Vol Avg: | 4763364 | Last Div: | 0 | Changes: | 0 |
| Beta: | -2.52 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Tue Aug 19 2003 | Empoloyees: | 1 | ||
| CUSIP: | CIK: | ISIN: | US74371E2046 | Country: | US | ||
| CEO: | Mr. Roger Baylis-Duffield | Website: | https://www.protxtm.com | ||||
ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines. Its medicines are formulated with highly-bioavailable plant extracts. The company is based in Boca Raton, Florida. ProText Mobility, Inc. is a subsidiary of Plandaí Biotechnology, Inc.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow